Becton Dickinson (BDX), first discussed here on March 17, 2009 at a price of $65.66, remains well-positioned for the new U.S. health care era.Look for Becton's 2010 revenue to surge 8-11% a a result of strong gains in its medical segment; diagnostics revenue should also rise substantially as demand for safety products and infectious disease/flu-related products sees steadily increasing global demand. Meanwhile, the bioservices unit revenue will likely trail the above, but still record 3-5% growth in 2010.
Tax Reform in This Election Year: It's Not Likely
Which Credit Card Rewards Does the IRS Care About?
Quest Diagnostics' stock (
The market slipped in and out of a stupor today as traders tried to decide whether the new $980 billion health care reform bill will help or hurt the economy if it passes.
Democrats finally reached
Unless you've been spending your summer vacation on a tropical beach with no television or internet access, you have seen that the public reception to Congress' proposals for heathcare reform have not exactly been well accepted. I mean, nut jobs showing up to town hall meetings with guns strapped to their legs isn't really the norm.
Could a tax on health care premiums, applied to both businesses and individuals, slow the increase in health insurance premiums?
The first half of 2009 has whizzed by in what seems like a macroeconomic eye-blink. Wasn't 

